Krystal Biotech, Inc. (KRYS)

Krystal Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	333.45	290.52	50.7	-	-	-
Revenue Growth (YoY)	247.53%	473.02%	-	-	-	-
Cost of Revenue	22.67	20.06	3.09	-	-	-
Gross Profit	310.78	270.45	47.61	-	-	-
Selling, General & Admin	120.35	113.69	98.4	78.84	41.99	15.06
Research & Development	56.87	53.57	46.43	42.46	27.88	17.94
Operating Expenses	177.22	167.26	144.83	121.3	69.88	33
Operating Income	133.56	103.2	-97.23	-121.3	-69.88	-33
Interest Expense	-	-	-	-	-1.49	-
Interest & Investment Income	29.47	29.66	22.62	5.22	0.2	0.83
EBT Excluding Unusual Items	163.02	132.86	-74.6	-116.08	-71.17	-32.17
Gain (Loss) on Sale of Assets	-	-	100	-	-	-
Legal Settlements	-25	-37.5	-12.5	-25	-	-
Pretax Income	138.02	95.36	12.9	-139.98	-69.57	-32.17
Income Tax Expense	14.06	6.2	1.97	-	-	-
Net Income	123.96	89.16	10.93	-139.98	-69.57	-32.17
Net Income to Common	123.96	89.16	10.93	-139.98	-69.57	-32.17
Net Income Growth	116.86%	715.58%	-	-	-	-
Shares Outstanding (Basic)	29	29	27	25	22	19
Shares Outstanding (Diluted)	30	30	28	25	22	19
Shares Change (YoY)	4.32%	7.16%	8.87%	14.85%	18.15%	18.15%
EPS (Basic)	4.32	3.12	0.40	-5.49	-3.13	-1.71
EPS (Diluted)	4.16	3.00	0.39	-5.49	-3.13	-1.71
EPS Growth	109.01%	669.23%	-	-	-	-
Free Cash Flow	129.32	119.18	-100.6	-153.55	-116.27	-40.93
Free Cash Flow Per Share	4.33	4.01	-3.63	-6.02	-5.24	-2.18
Gross Margin	93.20%	93.09%	93.90%	-	-	-
Operating Margin	40.05%	35.52%	-191.77%	-	-	-
Profit Margin	37.18%	30.69%	21.56%	-	-	-
Free Cash Flow Margin	38.78%	41.02%	-198.43%	-	-	-
EBITDA	135.91	105.66	-93.32	-118.65	-67.11	-31.15
EBITDA Margin	40.76%	36.37%	-184.07%	-	-	-
D&A For EBITDA	2.35	2.47	3.91	2.64	2.77	1.85
EBIT	133.56	103.2	-97.23	-121.3	-69.88	-33
EBIT Margin	40.05%	35.52%	-191.77%	-	-	-
Effective Tax Rate	10.19%	6.50%	15.24%	-	-	-

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q